Our latest analysis uncovered something the healthcare industry rarely delivers: actual good news
healthcare system is at a turning point as the dual epidemics of obesity and type 2 diabetes drive demand for advanced treatments
Although glucagon is traditionally understood as a counter-regulatory hormone that increases hepatic glucose production, its pharmacologic activation in balanced multi-receptor agonists may contribute to weight reduction by increasing energy expenditure, promoting fatty acid oxidation, and improving hepatic lipid metabolism
Compared with DPP-4 inhibitor initiation, GLP-1 receptor agonist initiation was associated with a higher risk of incident psoriasis, hazard ratio 1.19 with a 95% confidence interval of 1.11 to 1.28, and lower risks of pemphigus, hazard ratio 0.32, and bullous pemphigoid, hazard ratio 0.61, over up to four years
Without them, its harder to rely on whats actually inside
We showed that NAC, which increases cellular glutathione, repairs injury of the EHBD in that model 9